DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: MAYZENT (siponimod)
       *****************************************************
       #Post#: 3565--------------------------------------------------
       More skin cancer reported to FDA from patients on certain oral D
       MTs
       By: agate Date: February 24, 2022, 8:21 pm
       ---------------------------------------------------------
       From Multiple Sclerosis News Today (February 22, 2022)--"More
       Skin  Cancer Reported to FDA from Patients on Certain Oral
       DMTs":
  HTML https://bit.ly/3sgMJr6
       Mayzent (siponimod) and Gilenya (fingolimod) were the drugs
       where there was the most noticeable increase in skin cancer but
       several other MS drugs showed an increase as well.
       The article contains a statement that is worth noting:
       [quote]However, “evidence is insufficient to support a causative
       link,” the researchers wrote.[/quote]
       *****************************************************